Is SBIO or JNJ a better dividend investment in 2026?

SBIO currently yields 2.25% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between SBIO and JNJ?

SBIO has a forward dividend yield of 2.25% ($1.17/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1.11 percentage points.

Home › Compare › SBIO vs JNJ

SBIO vs JNJ: Dividend Comparison 2026

SBIO yields 2.25% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SBIO wins by $3.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SBIO

● Live price

2.25%

Share price

$52.25

Annual div

$1.17

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$23.0K

Annual income

$259.80

Full SBIO calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SBIO vs JNJ

📍 SBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SBIO	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SBIO + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SBIO pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBIO

Annual income on $10K today (after 15% tax)

$190.99/yr

After 10yr DRIP, annual income (after tax)

$220.83/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $482.78/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBIO + JNJ for your $10,000?

SBIO: 50%JNJ: 50%

100% JNJ50/50100% SBIO

Portfolio after 10yr

$21.5K

Annual income

$543.79/yr

Blended yield

2.53%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SBIO

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBIO buys

JNJ buys

Politician	Chamber	Ticker	Type	Amount	Date
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2023-04-17
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2023-04-17
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2023-02-15
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2023-02-15
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2022-10-04
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2022-10-04
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2022-03-07
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2022-03-07
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2021-12-31
Thomas R. Carper	🏛 Senate	$SBIO	▼ Sell	$1,001 - $15,000	2021-12-31

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSBIOJNJ

Forward yield	2.25%	3.36% ✓
Annual dividend / share	$1.17	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$23.0K ✓	$20.0K
Annual income after 10y	$259.80	$827.78 ✓
Total dividends collected	$2.4K	$5.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SBIO vs JNJ ($10,000, DRIP)

Year	SBIO Portfolio	SBIO Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$10,925	$224.69	$10,676	$355.77	+$249.00 → SBIO
2	$11,919	$229.41	$11,407	$389.39	+$512.00 → SBIO
3	$12,987	$233.91	$12,198	$426.53	+$789.00 → SBIO
4	$14,134	$238.20	$13,056	$467.62	+$1.1K → SBIO
5	$15,366	$242.28	$13,987	$513.12	+$1.4K → SBIO
6	$16,688	$246.16	$14,998	$563.56	+$1.7K → SBIO
7	$18,106	$249.85	$16,098	$619.52	+$2.0K → SBIO
8	$19,627	$253.35	$17,295	$681.69	+$2.3K → SBIO
9	$21,257	$256.66	$18,599	$750.82	+$2.7K → SBIO
10	$23,005	$259.80	$20,022	$827.78	+$3.0K → SBIO

SBIO vs JNJ: Complete Analysis 2026

SBIO — Stock

The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Full SBIO Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SBIO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBIO vs SCHD SBIO vs JEPI SBIO vs O SBIO vs KO SBIO vs MAIN SBIO vs ABBV SBIO vs MRK SBIO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.